Plasmid vector of human Brachyury.
Alternative name | SET-0227_12 |
---|---|
Clone info. | Plasmid vector of human Brachyury. |
Comment | PCR cloning, forward primer: atgagctcccctggcaccga; reverse primer: tcacatggaaggtggcgaca. Nucleotide substitution G1565A (V358I) to NM_003181.2. |
Vector backbone | pGEM-3Zf(+) (Plasmid) |
Selectable markers | Amp^r |
Gene/insert name | Human T, brachyury homolog cDNA |
Depositor|Developer | Nakamura, Yukio | |
Please check terms and conditions set forth by the depositor, which are specified in the RIKEN BRC Catalog and/or Web Catalog.
Ordering forms | Order form [Credit Card Payment] [Bank Transfer Payment] [Example of order form ] MTA, for use for not-for-profit academic purpose [Word] [Example of MTA ] Please visit Information of Request for Distribution.[link] |
---|---|
Terms and conditions for distribution | 1. The RECIPIENT agrees to use the BIOLOGICAL RESOURCE only for academic research in the non-profit organization. 2. In publishing the research results to be obtained by use of the BIOLOGICAL RESOURCE, an acknowledgment to the DEPOSITOR is requested. |
必要書類 | 提供依頼書 [依頼書の記入例 ] 提供同意書 (MTA, 非営利学術目的用)[Word] [MTAの記入例 ] 手続きの概要は、「提供申込みについて[link]」をご覧ください。 |
---|---|
MTAに書く使用条件 | 1. 本件リソースは非営利機関にのみ提供し、学術研究にのみ利用することができる。 2. 謝辞の表明を必要とする。 |
Catalog # | Resource name | Shipping form | Fee (non-profit org.) |
---|---|---|---|
RDB06755 | pGEM3Zf_hsBrachyury | DNA solution |
Materials & Methods section:
The pGEM3Zf_hsBrachyury was provided by the RIKEN BRC through the National BioResource Project of the MEXT, Japan (cat. RDB06755). |
Reference section:
Further references such as user reports and related articles (go to bottom)
RIKEN BRC has sequenced portions of this material for quality test.
Please review the QC test results indicated by icon as well as clone information before placing your order.
Test sheet | RDB12790_A4Em.pdf |
---|
Nucleotide sequence of a portion of this resource (if available).
Primer: M13_-40 Sequence file: RDB12790_A4Ema.seq |
---|
>06755_12790_A4Em_M13(-40)_A11_02.ab1 1 AAGCGCGATT GTATACGACT CACTATAGGG CGAATTCGAG CTCGGTACCC GGGGATCCTC 61 TAGAGTCTCA CATGGAAGGT GGCGACACAG GTGTCCATGA GGCTATGAGG CGGCCTTGGG 121 CTGCGGCGTC GTACTGGCTG TCCACGATGT CTGTGGCCGC GGCCGCCCCT TCGTACAGTG 181 GGGATCCCGA GGAAGAGGGC GCCGAGACCG GATGGGTGAG GGGTGTGTAG TGCGCGGGGG 241 AGCCCCGGAA GAACTGGGCC CCCAGCCCGT TGGACACGGC TGCTGCCTGG GAGCCCGGGG 301 TGATGGCGCC GTTGCTCACA GACCACAGGC TGGGGTACTG ACTGGAGCTG GTAGGTGGGC 361 TGGCATTGTG GCTCACGGGG AGCATGCTGG GATGGGCAGG CATTCCAAGG CTGGACCAAT 421 TGTCATGGGA TTGCAGCATG GATAAACATG CAGGTGAGTT GTCAGAATAG GTTGGAGAAT 481 TGTTCCGATG AGCATAGGGG CTGGGGTAGG GTGAGGACCG GTGGCTCCTC AGGGTTGGGT 541 ACCTGTCACA GCTGTGCGTG GAGGGGAGGG AGAGGGCACC TCCAAACTGA GGATGAGGAT 601 TTGCAGGTGG ACACAGGGTG CTGGTTCCAG GAAGAAGCCA CCCCCATTGG GAGTACCCAG 661 GTTGCTGGCT GTCTCCGGGT TCCTCCATCA TCTCTTTGTG ATCACTTCTT TCCTTTGCAT 721 CAAGGAAAGC TTTTGCAAAT GGATTGTACT TAATTTTAAG AGCTGTGATC TCCTCGTTCT 781 GATAAGCAGT CACCGCTATG AACTGGGTCT CAGGGAAGCA GTGGCTGGTG ATCATGCGCT 841 GTGGACCCCC AACTCTCACT ATGTGGATTC GAGGCTCATA CTTATGCAAG GAGTTCAGCA 901 TGATCTGGCC CCCTCCGTTG AGCTTGTTGG TGAGCTTGAC TTTGCTGAAG GAGACGGGAG 961 CCTTCATCCA GTGGGCCCCG AAGTTTGGGC GAGTCGGGGT GGATGTAGAC GCAGCTGGGC 1021 GCCCTGCGGC TCCGGCTTGC CCCCCCGGCA CCCATTTCCC CGTTTCACGT ACTTTCCAGC 1081 GATGGATGGT TCCGCCGGCC ACCGGAAGTC AGCCAGAGAA GTACATGGCG TTTGGGGATC 1141 AGGCCCAGAA CCACGGTTTC AACT // |
Primer: Reverse2 Sequence file: RDB12790_A4Emb.seq |
>06755_12790_A4Em_Reverse2_B11_05.ab1 1 AATACATGAA TTACGCCAGC TATTTAGGTG ACACTATAGA ATACTCAAGC TTGCATGCCT 61 GCAGGTCATG AGCTCCCCTG GCACCGAGAG CGCGGGAAAG AGCCTGCAGT ACCGAGTGGA 121 CCACCTGCTG AGCGCCGTGG AGAATGAGCT GCAGGCGGGC AGCGAGAAGG GCGACCCCAC 181 AGAGCGCGAA CTGCGCGTGG GCCTGGAGGA GAGCGAGCTG TGGCTGCGCT TCAAGGAGCT 241 CACCAATGAG ATGATCGTGA CCAAGAACGG CAGGAGGATG TTTCCGGTGC TGAAGGTGAA 301 CGTGTCTGGC CTGGACCCCA ACGCCATGTA CTCCTTCCTG CTGGACTTCG TGGCGGCGGA 361 CAACCACCGC TGGAAGTACG TGAACGGGGA ATGGGTGCCG GGGGGCAAGC CGGAGCCGCA 421 GGCGCCCAGC TGCGTCTACA TCCACCCCGA CTCGCCCAAC TTCGGGGCCC ACTGGATGAA 481 GGCTCCCGTC TCCTTCAGCA AAGTCAAGCT CACCAACAAG CTCAACGGAG GGGGCCAGAT 541 CATGCTGAAC TCCTTGCATA AGTATGAGCC TCGAATCCAC ATAGTGAGAG TTGGGGGTCC 601 ACAGCGCATG ATCACCAGCC ACTGCTTCCC TGAGACCCAG TTCATAGCGG TGACTGCTTA 661 TCAGAACGAG GAGATCACAG CTCTTAAAAT TAAGTACAAT CCATTTGCAA AAGCTTTCCT 721 TGATGCAAAG GAAAGAAGTG ATCACAAAGA GATGATGGAG GAACCCGGAG ACAGCCAGCA 781 ACCTGGGTAC TCCCAATGGG GGTGGCTTCT TCCTGGAACC AGCACCCTGT GTCCACCTGC 841 AAATCCTCAT CCTCAGTTTG GAGGTGCCCT CTCCCTCCCC TCCACGCACA GCTGTGACAG 901 GTACCCAACC CTGAGGAGCC ACCGGTCCTC ACCCTACCCC AGCCCCTATG CTCATCGGAA 961 CAATTCTCCA ACCTATTCTG ACAACTCACC TGCATGTTAT CCATGCTGCA ATCCCATGAC 1021 AATTGGTCCA GCCTTGGTAA TGCCTGCCCA TCCCAGCATG CTCCCCGTGA GCCACAATGC 1081 CAGCCACTAC AGCTCCAGTC AGTAACCCCA GCTGTGATCT GTGAGCACCG ACGGCAATCA 1141 CCCCCGGGAC CTCCCAGGCC AGGCC // |
Please visit Sequencing and PCR primers for primer information.
Original, user report and related articles
Featured content